SCHEMBL2329671

SCHEMBL2329671

CC(C)=C(CCN)C(N)=O

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PAOX Q6QHF9 2/20 0.37
LMNA P02545 2/20 0.35
BLM P54132 2/20 0.35
ALOX15 P16050 1/20 0.35
PMP22 Q01453 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
GRIK1 P39086 1/20 0.32
ALDH1A1 P00352 1/20 0.32
GABRR3 A8MPY1 1/20 0.31
GABRP O00591 1/20 0.31
GABRD O14764 1/20 0.31
HDAC3 O15379 1/20 0.31
GABBR2 O75899 1/20 0.31
CYP1A2 P05177 1/20 0.31
THRB P10828 1/20 0.31
GABRA1 P14867 1/20 0.31
TSHR P16473 1/20 0.31
GABRB1 P18505 1/20 0.31
GABRG2 P18507 1/20 0.31
GABRR1 P24046 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL36269 0.85 PAOX (0.44) PAOXLMNABLMALOX15PMP22
Hydrochloric Acid SCHEMBL31621224 0.83 PAOX (0.43) PAOXLMNABLMALOX15PMP22
SCHEMBL2597380 0.83 PAOX (0.54) PAOXLMNABLMALOX15TDP1
SCHEMBL10707227 0.81 PAOX (0.58) PAOXLMNABLMALOX15ALDH1A1
SCHEMBL1720979 0.79 CES1 (0.41) LMNABLMALOX15PMP22TDP1
SCHEMBL8762451 0.79 ALDH1A1 (0.53) PAOXLMNABLMALOX15PMP22
SCHEMBL724564 0.79 GRIK1 (0.46) PAOXLMNABLMALOX15GRIK1
Sulfuric Acid SCHEMBL17078380 0.78 PAOX (0.39) PAOXLMNABLMALOX15PMP22
SCHEMBL1033713 0.78
Ammonia Solution, Strong SCHEMBL4395391 0.77 CES1 (0.39) LMNABLMALOX15PMP22TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101861342-B High definition printing with waterborne inks on non-porous substrates RHODIA 2012-11-21 CN claimed
WO-2026106695-A1 TARGETED NANOPARTICLES ENCAPSULATING WATER-SOLUBLE THERAPEUTICS, METHODS OF PRODUCTION, AND USE OPTIMEOS LIFE SCIENCES, INC. (US) 2026-05-21 WO disclosed
US-12605344-B2 Nanoparticles encapsulating soluble biologics, therapeutics, and imaging agents THE TRUSTEES OF PRINCETON UNIVERSITY (US) 2026-04-21 US disclosed
EP-4021425-B1 COMB POLYMER AND BLOCK COPOLYMER STABILIZED NANOPARTICLES ENCAPSULATING NUCLEIC ACIDS AND OTHER SOLUBLE HYDROPHILIC COMPOUNDS UNIV PRINCETON (US) 2025-04-16 EP disclosed
US-20250057780-A1 NANOPARTICLES AND METHODS OF PRODUCTION FOR THE ENCAPSULATION OF NUCLEIC ACIDS OPTIMEOS LIFE SCIENCES, INC. (US) 2025-02-20 US disclosed
US-12186436-B2 Triblock copolymer stabilizers for the formation of nanoparticles encapsulating soluble biologics, therapeutics, and imaging agents THE TRUSTEES OF PRINCETON UNIVERSITY (US) 2025-01-07 US disclosed
EP-4452229-A2 NANOPARTICLES AND METHODS OF PRODUCTION FOR THE ENCAPSULATION OF NUCLEIC ACIDS Optimeos Life Sciences, Inc. (US) 2024-10-30 EP disclosed
EP-4299058-A2 PROCESS FOR ENCAPSULATING SOLUBLE BIOLOGICS, THERAPEUTICS, AND IMAGING AGENTS The Trustees of Princeton University (US) 2024-01-03 EP disclosed
EP-3160449-B1 PROCESS FOR ENCAPSULATING SOLUBLE BIOLOGICS, THERAPEUTICS, AND IMAGING AGENTS UNIV PRINCETON (US) 2023-12-13 EP disclosed
US-20230356169-A1 METHOD FOR CONTROLLING ENCAPSULATION EFFICIENCY AND BURST RELEASE OF WATER SOLUBLE MOLECULES FROM NANOPARTICLES AND MICROPARTICLES PRODUCED BY INVERSE FLASH NANOPRECIPITATION THETRUSTEES OF PRINCETON UNIVERSITY (US) 2023-11-09 US disclosed
CN-1501166-A Radiation-sensitive resin composition JSR株式会社 2004-06-02 CN disclosed
WO-2003018671-A1 MULTICOMPONENT SUPERABSORBENT GEL PARTICLES BASF AKTIENGESELLSCHAFT (DE) 2003-03-06 WO disclosed
CN-1332205-A Radiation-sensitive resin composition JSR CORP (JP) 2002-01-23 CN disclosed
US-6171774-B1 YELLOW IMAGE-FORMING EMULSION LAYER CONTAINS A YELLOW DYE-FORMING COUPLER AND AN ORGANIC SOLVENT-SOLUBLE POLYMER KONICA CORPORATION (JP) 2001-01-09 US disclosed
US-5928850-A WITH OXAZOLIDIONE-TYPE YELLOW COUPLER KONICA CORPORATION (JP) 1999-07-27 US disclosed
EP-0855412-A2 Process for preparing polymers of N-vinyl caprolactam BASF AKTIENGESELLSCHAFT (DE) 1998-07-29 EP disclosed
EP-0219101-A2 Silver halide photographic material KONICA CORPORATION (JP) 1987-04-22 EP disclosed
EP-0186494-A2 Heat-developable color photo-sensitive material KONICA CORPORATION (JP) 1986-07-02 EP disclosed
EP-0174177-A2 Heat-developable color photo-sensitive material KONICA CORPORATION (JP) 1986-03-12 EP disclosed
EP-0157639-A2 Heat-developable multilayered color photo-sensitive material KONICA CORPORATION (JP) 1985-10-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12605344-B2 Nanoparticles encapsulating soluble biologics, therapeutics, and imaging agents SPPL2B, SPPL2A, YWHAZ PAOX 4573/4885LMNA 1520/4885BLM 3443/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.